Table 1.
Characteristics | Values |
---|---|
Patients | n = 27 with 28 lesions |
Age | |
Mean age ± std. | 4.5 ± 3.2 years |
Range | 0.3–11.5 years |
Diagnosis | |
Neuroblastoma | n = 18 (one bilateral resulting in 19 NB lesions) |
Ganglioneuroblastoma | n = 7 |
Ganglioneuroma | n = 2 |
Tumor localizationa | |
Cervical | n = 1 |
Thoracic | n = 4a |
Abdominal (extraadrenal) | n = 16a |
Adrenal | n = 7b |
Pelvic | n = 1 |
Genetic alterations | |
MYCN amplification | n = 6 |
Positive 1p-deletion | n = 4 |
Imbalanced 1p-status | n = 2 |
123I-MIBG scintigraphy findings | |
123I-MIBG: positive | n = 11 |
123I-MIBG: negative | n = 1 |
123I-MIBG: unclear | n = 1 |
Risk group stratification | |
High risk | n = 14 |
Intermediate risk | n = 7 |
Low risk | n = 6 |
aOne case of thoracic-abdominal manifestation
bOne bilateral manifestation
Abbreviations: 123I-MIBG 123Iodine-meta-iodobenzylguanidine